{"doi":"10.1016/j.jtho.2024.01.017","title":"Immunotherapy Is a Good Standard Option for Patients With Malignant Pleural Mesothelioma, Despite the Real-World Results From Australia","abstract":null,"journal":"Journal of Thoracic Oncology","year":2024,"id":630467,"datarank":0.31191623125197543,"base_score":2.0794415416798357,"endowment":2.0794415416798357,"self_citation_contribution":0.31191623125197543,"citation_network_contribution":0.0,"self_endowment_contribution":0.31191623125197543,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":7,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":65214,"name":"Paul Baas","orcid":"0000-0001-7018-9556","position":1,"is_corresponding":false},{"id":1633318,"name":"Illaa Smesseim","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Immunotherapy Is a Good Standard Option for Patients With Malignant Pleural Mesothelioma, Despite the Real-World Results From Australia","abstract":null,"is_dataset_classified":null,"base_score":2.0794415416798357,"endowment":2.0794415416798357,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"38582547","pmcid":null,"openalex_id":"https://openalex.org/W4393943406","authors":[],"funders":[],"total_grants":0,"fwci":1.9902,"citation_percentile":0.86498428,"influential_citations":0,"citation_trend":[{"year":2024,"count":1},{"year":2025,"count":3},{"year":2026,"count":3}],"oa_status":"bronze","license":"http://www.elsevier.com/open-access/userlicense/1.0/","oa_locations":[{"url":"http://www.jto.org/article/S1556086424000376/pdf","host_type":"journal"},{"url":"http://www.jto.org/article/S1556086424000376/pdf","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S1556086424000376?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S1556086424000376?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.jtho.2024.01.017","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/38582547","host_type":"repository"}],"fields_of_study":["Occupational and environmental lung diseases","Pleural and Pulmonary Diseases","Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis"],"mesh_terms":["Mesothelioma, Malignant","Humans","Immunotherapy","Lung Neoplasms","Mesothelioma","Pleural Neoplasms"],"keywords":["Medicine","Mesothelioma","Immunotherapy","Oncology","Intensive care medicine","Internal medicine","Pathology","Cancer"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-05T21:22:01.413959Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}